Entering text into the input field will update the search result below

Terns Pharmaceuticals GAAP EPS of -$0.56

Mar. 03, 2022 5:42 PM ETTerns Pharmaceuticals, Inc. (TERN)By: Urvi Shah, SA News Editor
  • Terns Pharmaceuticals press release (NASDAQ:TERN): Q4 GAAP EPS of -$0.56.
  • Q4 Net loss $14.24M.
  • As of December 31, 2021, cash, cash equivalents and marketable securities were $166.0 million as compared with $74.9 million as of December 31, 2020.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.